Coping with common gastrointestinal symptoms in the community: A global perspective on Heartburn, Constipation, Bloating, and Abdominal Pain/Discomfort May 2013

Journal of Clinical Gastroenterology

Volumn 48, Issue 7, 2014, Pages 567-578

  Hunt, Richard ^a   Quigley, Eamonn ^a   Abbas, Zaigham ^a   Eliakim, Abraham ^a   Emmanuel, Anton ^a   Goh, Khean Lee ^a   Guarner, Francisco ^a   Katelaris, Peter ^a   Smout, Andre ^a   Umar, Mohammad ^a   Whorwell, Peter ^a   Johanson, John ^a   Saenz, Roque ^a   Besançon, Luc ^a   Ndjeuda, Edith ^a   Horn, John ^a   Hungin, Pali ^a   Jones, Roger ^a   Krabshuis, Justus ^a   Lemair, Anton ^a   Kopp, Leah ^a   more..

^a World Gastroenterology Organisation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIPARKINSON AGENT; BULKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GUAR GUM; ISPAGULA; LAXATIVE; METOCLOPRAMIDE; NON PRESCRIPTION DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; BLOATING; CLINICAL FEATURE; COMMUNITY; CONSTIPATION; COPING BEHAVIOR; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM EXAMINATION; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GENERAL PRACTITIONER; HEARTBURN; HUMAN; IRON THERAPY; LIFESTYLE MODIFICATION; MEDICAL SPECIALIST; PHARMACIST; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SELF CARE; SELF HELP; TREATMENT OUTCOME; WEIGHT REDUCTION; HEALTH; PRACTICE GUIDELINE; PRESSURE;

ABDOMINAL PAIN; CONSTIPATION; GLOBAL HEALTH; HEARTBURN; HUMANS; PRESSURE;

EID: 84904060506     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000141     Document Type: Review

References (30)

1. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38: 1569-1580
2. Hungin AP, Whorwell PJ, Tack J, et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003;17:643-650
3. Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut. 1998;43: 770-774
4. Quigley EM, Locke GR, Mueller-Lissner S, et al. Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther. 2006;24:411-419
5. Mueller-Lissner S, Quigley EM, Helfrich I, et al. Drug treatment of chronic-intermittent abdominal cramping and pain: a multi-national survey on usage and attitudes. Aliment Pharmacol Ther. 2010;32:472-477
6. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012;107:657-666
7. Kehar M, Yadav SP, Sachdeva A. Constipation in children. J Int Med Sci Acad. 2012;25:31-33
8. Drossman DA, Funch-Jensen P, Janssens J, et al. Identification of subgroups of functional bowel disorders. Gastroenterol Int. 1990;3:159-172
9. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25:252-258
10. Galmiche JP, Clouse RE, Bálint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459-1465
11. Dent J, Vakil N, Jones R, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010;59:714-721
12. Thomas V, Rangan K, Kumar S. Occurrence of functional heartburn in patients with symptoms of gastroesophageal reflux disease (GERD) not responding to proton pump inhibitors (PPI) [abstract]. Am J Gastroenterol. 2011;106(suppl 2):S25
13. Gao Y, Hu N, Han X, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer. 2009;9:269
14. Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56:931-950
15. Berardi RR. Handbook of Nonprescription Drugs: an Interactive Approach to Self-care. 16th ed. Washington, DC: American Pharmacists Association; 2009
16. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383-1391. Available at: http://www.gastrojournal. org/article/S0016-5085(08)01606-5/fulltext.
17. Smith L. Updated ACG guidelines for diagnosis and treatment of GERD. Am Fam Physician. 2005;71:2376-2382. Available at: . http://www.aafp.org/afp/2005/ 0615/p2376.html
18. Gupta V, Moshiree B, Verne GN. Treatment of pain symptoms in irritable bowel syndrome patients. Drugs Today (Barc). 2004;40:829-836
19. Mertz HR. Irritable bowel syndrome. N Engl J Med. 2003; 349:2136-2146
20. Gibson PR. Food intolerance in functional bowel disorders. J Gastroenterol Hepatol. 2011;26(suppl 3):128-131
21. Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet. 2011;24:487-495
22. Dorn SD, Meek PD, Shah ND. Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics. Clin Gastroenterol Hepatol. 2011;9:1078-1085
23. Quigley EM, Abdel-Hamid H, Barbara G, et al. A global perspective on irritable bowel syndrome. A consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012;46:356-366
24. Rome Foundation. Appendix D: Rome III psychosocial alarm questionnaire for the functional GI disorders. In: Drossman DA, ed. Rome III: the Functional Gastrointestinal Disorders. 3rd ed. MacLean, VA: Degnon Associates; 2006:953-959. Available at: . http://www.romecriteria.org/pdfs/PsychoAlarm Q.pdf
25. World Gastroenterology Organisation. World Gastroenterology Organisation Global Guidelines. Irritable bowel syndrome: a global perspective. April 2009. Available at: http://www.world gastroenterology.org/irritable-bowel-syndrome. html. Accessed July 26, 2013
26. Lacy BE, Gabbard SL, Crowell MD. Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air? Gastroenterol Hepatol (NY). 2011;7:729-739
27. World Gastroenterology Organisation. World Gastroenterology Organisation Global Guidelines. Probiotics and Prebiotics. October 2011. Available at: http://www.worldgastro enterology.org/probiotics-prebiotics.html. Accessed July 26, 2013
28. Drossman DA, Toner BB, Whitehead WE, et al. Cognitivebehavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19-31
29. Accarino A, Perez F, Azpiroz F, et al. Intestinal gas and bloating: effect of prokinetic stimulation. Am J Gastroenterol. 2008;103:2036-2042
30. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25: 599-608.